Marked biochemical difference in amyloid proportion between intra- and extraocular tissues in a liver-transplanted patient with hereditary ATTR amyloidosis |
| |
Authors: | Tsuneaki Yoshinaga Fuyuki Kametani Yoshiki Sekijima Yasuhiro Iesato Teruyoshi Miyahara |
| |
Affiliation: | 1. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan,;2. Department of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan,;3. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan,;4. Department of Biological Sciences for Intractable Neurological Diseases, Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan,;5. Department of Ophthalmology, Shinshu University School of Medicine, Matsumoto, Japan, |
| |
Abstract: | In order to elucidate the pathomechanism of ocular amyloid formation in a liver-transplanted patient with hereditary ATTR amyloidosis, we investigated detailed biochemical features of ocular amyloid. The patient was a 49-year-old woman with V30M transthyretin (TTR) variant (p.TTRV50M), who underwent ophthalmectomy due to corneal rupture 10 years after liver transplantation (LT). The amyloid was selectively isolated from several portions in intra- and extraocular tissues using a laser microdissection (LMD) system and analyzed by liquid chromatography–tandem mass spectrometry to determine the composition percentage of wild-type and variant TTR in the isolated amyloid. Biochemical analysis revealed that the amyloid consisted mainly of variant TTR in intraocular tissues with a percentage >?80%. On the contrary in the extraocular muscles, wild-type TTR was the main component of the amyloid with a percentage of ~70%. Our data indicate that intraocular amyloid formation strongly depends on locally synthesized variant TTR and the contribution of wild-type TTR to amyloid formation is quite limited. |
| |
Keywords: | Laser microdissection hereditary ATTR amyloidosis liver transplantation ocular amyloidosis transthyretin |
|
|